Hantz Financial Services’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $3.11M | Sell |
28,043
-1,080
| -4% | -$120K | 0.05% | 268 |
|
2025
Q1 | $3.26M | Sell |
29,123
-34,443
| -54% | -$3.86M | 0.06% | 259 |
|
2024
Q4 | $5.87M | Sell |
63,566
-7,260
| -10% | -$671K | 0.1% | 195 |
|
2024
Q3 | $5.94M | Sell |
70,826
-2,422
| -3% | -$203K | 0.11% | 197 |
|
2024
Q2 | $5.03M | Sell |
73,248
-4,224
| -5% | -$290K | 0.1% | 207 |
|
2024
Q1 | $5.68M | Sell |
77,472
-26,653
| -26% | -$1.95M | 0.11% | 200 |
|
2023
Q4 | $8.44M | Sell |
104,125
-6,026
| -5% | -$488K | 0.18% | 161 |
|
2023
Q3 | $8.26M | Buy |
110,151
+42,979
| +64% | +$3.22M | 0.21% | 144 |
|
2023
Q2 | $5.18M | Buy |
67,172
+400
| +0.6% | +$30.8K | 0.13% | 193 |
|
2023
Q1 | $5.54M | Buy |
66,772
+1,063
| +2% | +$88.2K | 0.15% | 177 |
|
2022
Q4 | $5.64M | Buy |
65,709
+2,903
| +5% | +$249K | 0.17% | 169 |
|
2022
Q3 | $3.87M | Buy |
62,806
+1,586
| +3% | +$97.8K | 0.13% | 195 |
|
2022
Q2 | $3.78M | Buy |
61,220
+2,701
| +5% | +$167K | 0.13% | 197 |
|
2022
Q1 | $3.48M | Buy |
58,519
+3,906
| +7% | +$232K | 0.1% | 220 |
|
2021
Q4 | $3.97M | Buy |
54,613
+3,117
| +6% | +$226K | 0.11% | 197 |
|
2021
Q3 | $3.6M | Buy |
51,496
+5,805
| +13% | +$405K | 0.12% | 197 |
|
2021
Q2 | $3.15M | Buy |
45,691
+3,343
| +8% | +$230K | 0.12% | 200 |
|
2021
Q1 | $2.74M | Buy |
42,348
+533
| +1% | +$34.4K | 0.11% | 209 |
|
2020
Q4 | $2.44M | Buy |
41,815
+270
| +0.6% | +$15.7K | 0.11% | 207 |
|
2020
Q3 | $2.63M | Sell |
41,545
-576
| -1% | -$36.4K | 0.13% | 189 |
|
2020
Q2 | $3.24M | Buy |
42,121
+770
| +2% | +$59.2K | 0.18% | 166 |
|
2020
Q1 | $3.09M | Buy |
+41,351
| New | +$3.09M | 0.21% | 148 |
|